Kiora Pharmaceuticals Inc (KPRX)
0.493
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
0.51
+0.02
(+3.45%)
After-Hours: 20:00
Kiora Pharmaceuticals Net Income (Quarterly): 13.45M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 13.45M |
| December 31, 2023 | -2.269M |
| September 30, 2023 | -5.763M |
| June 30, 2023 | -2.614M |
| March 31, 2023 | -1.868M |
| December 31, 2022 | -2.498M |
| September 30, 2022 | -5.119M |
| June 30, 2022 | -2.401M |
| March 31, 2022 | -3.565M |
| December 31, 2021 | -6.182M |
| September 30, 2021 | -3.035M |
| June 30, 2021 | -2.543M |
| March 31, 2021 | -2.011M |
| December 31, 2020 | -1.186M |
| September 30, 2020 | -2.007M |
| June 30, 2020 | -1.717M |
| March 31, 2020 | -1.952M |
| December 31, 2019 | -2.702M |
| September 30, 2019 | -3.428M |
| June 30, 2019 | -1.837M |
| March 31, 2019 | 0.8708M |
| December 31, 2018 | -2.528M |
| September 30, 2018 | -3.124M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.780M |
| March 31, 2018 | -2.379M |
| December 31, 2017 | -2.831M |
| September 30, 2017 | -4.140M |
| June 30, 2017 | -3.327M |
| March 31, 2017 | -2.920M |
| December 31, 2016 | -3.701M |
| September 30, 2016 | -3.377M |
| June 30, 2016 | -3.823M |
| March 31, 2016 | -2.442M |
| December 31, 2015 | -2.69M |
| September 30, 2015 | -1.356M |
| June 30, 2015 | -1.541M |
| March 31, 2015 | -11.03M |
| December 31, 2014 | -0.4165M |
| September 30, 2014 | 0.3096M |
| June 30, 2014 | -0.7052M |
| March 31, 2014 | -0.9618M |
| December 31, 2013 | -0.8643M |
| September 30, 2013 | -0.8888M |
| June 30, 2013 | -0.9623M |
| March 31, 2013 | -1.164M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-6.182M
Minimum
Dec 2021
13.45M
Maximum
Mar 2024
-2.062M
Average
-2.450M
Median
Net Income (Quarterly) Benchmarks
| Precision Optics Corp Inc | -0.3171M |
| Perspective Therapeutics Inc | -12.28M |
| Electromed Inc | 1.493M |
| Xtant Medical Holdings Inc | -4.40M |
| Asensus Surgical Inc | -22.50M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 16.00M |
| Total Expenses (Quarterly) | 2.790M |
| EPS Diluted (Quarterly) | 0.38 |
| Enterprise Value | -18.33M |
| Profit Margin (Quarterly) | 84.08% |
| Earnings Yield | -323.4% |
| Operating Earnings Yield | 95.10% |
| Normalized Earnings Yield | -212.98 |